SMTL ID : 7nh4.1

Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x UCE: ~{N}-[3-[1-[[4-[5-(hydroxymethyl)-3-phenyl-pyridin-2-yl]phenyl]methyl]piperidin-4-yl]-2-oxidanylidene-1~{H}-benzimidazol-5-yl]propanamide(Covalent)

UCE.1: 21 residues within 4Å: Chain A: Y.18, Q.79, W.80, I.84, S.205, L.210, T.211, L.264, K.268, V.270, Y.272, R.273, D.274, I.290, T.291, D.292, C.296, K.297, C.310, G.311 Ligands: ACT.2 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:W.80, A:I.84, A:L.210, A:L.210, A:L.264, A:L.264, A:V.270, A:Y.272, A:D.292 Hydrogen bonds: A:R.273, A:R.273, A:K.297 Salt bridges: A:D.274 pi-Stacking: A:W.80 pi-Cation interactions: A:R.273

2 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 9 residues within 4Å: Chain A: W.80, S.205, R.206, H.207, L.210, T.211, A.212, L.213 Ligands: UCE.1 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:W.80 Hydrogen bonds: A:S.205, A:H.207, A:T.211 ACT.3: 6 residues within 4Å: Chain A: E.17, N.54, F.55, R.86, R.273, Y.326 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.326 Salt bridges: A:R.86, A:R.273

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Quambusch, L. et al., Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Nat Commun (2021)

Release Date

2021-09-08

Peptides

RAC-alpha serine/threonine-protein kinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

RAC-alpha serine/threonine-protein kinase

Related Entries With Identical Sequence